Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.35 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.35 |
| ▸ | HTR3B | O95264 | 1/20 | 0.35 |
| ▸ | HTR3A | P46098 | 1/20 | 0.35 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.35 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7225689 | 0.89 | FAAH (0.43) | FAAHCA12CA1CA2CA4 | |
| SCHEMBL7232713 | 0.88 | HDAC1 (0.48) | CA12CA1CA2CA4ACKR3 | |
| SCHEMBL7229511 | 0.88 | FAAH (0.44) | FAAHCA12CA1CA2CA4 | |
| SCHEMBL7223831 | 0.88 | HDAC1 (0.48) | CA12CA1CA2CA4ACKR3 | |
| SCHEMBL7224837 | 0.88 | CA12 (0.38) | CA12CA1CA2CA4ACKR3 | |
| SCHEMBL7231820 | 0.86 | HDAC1 (0.36) | CA12CA1CA2CA4ACKR3 | |
| SCHEMBL7231021 | 0.85 | HDAC1 (0.50) | FAAHHDAC1HDAC6HTR3EHTR3B | |
| SCHEMBL7231428 | 0.85 | FAAH (0.46) | FAAHCA12CA1CA2CA4 | |
| SCHEMBL7073214 | 0.85 | TUBB4A (0.47) | FAAHCA12CA1CA2CA4 | |
| SCHEMBL7230181 | 0.84 | FAAH (0.47) | FAAHCA12CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6562816-B2 | Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects | PHARMACIA & UPJOHN COMPANY | 2003-05-13 | — | — | US | claimed |
| US-6562816-B2 | Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects | PHARMACIA & UPJOHN COMPANY | 2003-05-13 | — | — | US | disclosed |